Best TWAS P=1.76e-09 · Best GWAS P=1.05e-09 conditioned to 0.105
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Subcutaneous | TESC | 0.09 | 0.04 | lasso | 2 | 0.01 | 2.1e-02 | -4.6 | -5.1 | 2.8e-07 | 0.87 | 0.11 | 0.77 | FALSE |
2 | GTEx | Adipose Subcutaneous | FBXW8 | 0.12 | 0.04 | lasso | 6 | 0.02 | 1.2e-02 | -4.9 | -5.3 | 9.1e-08 | 0.81 | 0.08 | 0.72 | FALSE |
3 | GTEx | Cells Transformed fibroblasts | FBXW8 | 0.25 | 0.24 | lasso | 4 | 0.25 | 5.0e-19 | -5.6 | 5.5 | 4.0e-08 | -0.88 | 0.10 | 0.90 | FALSE |
4 | GTEx | Cells Transformed fibroblasts | RP11-231I16.1 | 0.16 | 0.18 | lasso | 2 | 0.16 | 2.5e-12 | -5.6 | 5.8 | 6.7e-09 | -0.94 | 0.06 | 0.94 | FALSE |
5 | GTEx | Nerve Tibial | FBXW8 | 0.17 | 0.17 | lasso | 3 | 0.19 | 2.5e-13 | -5.6 | -5.2 | 2.4e-07 | 0.78 | 0.09 | 0.91 | FALSE |
6 | GTEx | Spleen | FBXW8 | 0.36 | 0.16 | lasso | 2 | 0.12 | 5.8e-04 | -5.6 | -5.6 | 2.3e-08 | 0.90 | 0.04 | 0.82 | FALSE |
7 | GTEx | Testis | FBXW8 | 0.27 | 0.10 | lasso | 4 | 0.06 | 1.9e-03 | -5.6 | -5.3 | 1.1e-07 | 0.83 | 0.08 | 0.86 | FALSE |
8 | GTEx | Thyroid | FBXW8 | 0.14 | 0.08 | lasso | 3 | 0.07 | 2.3e-06 | -5.0 | -5.4 | 6.8e-08 | 0.93 | 0.13 | 0.87 | FALSE |
9 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | FBXW8 | 0.14 | 0.09 | lasso | 8 | 0.08 | 1.8e-07 | -5.6 | 5.5 | 3.4e-08 | -0.90 | 0.04 | 0.96 | FALSE |
10 | The Cancer Genome Atlas | Breast Invasive Carcinoma | FBXW8 | 0.16 | 0.17 | blup | 83 | 0.17 | 3.9e-34 | -5.7 | 5.8 | 5.0e-09 | -0.88 | 0.08 | 0.92 | FALSE |
11 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | FBXW8 | 0.09 | 0.04 | blup | 81 | 0.04 | 3.0e-03 | -4.9 | 5.5 | 3.8e-08 | -0.91 | 0.02 | 0.88 | FALSE |
12 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | FBXW8 | 0.20 | 0.22 | enet | 18 | 0.24 | 4.5e-26 | -5.7 | 5.3 | 1.2e-07 | -0.81 | 0.05 | 0.95 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | FBXW8 | 0.12 | 0.17 | enet | 12 | 0.20 | 1.2e-21 | -5.7 | 5.8 | 5.5e-09 | -0.90 | 0.15 | 0.85 | FALSE |
14 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | FBXW8 | 0.10 | 0.10 | lasso | 7 | 0.09 | 7.5e-06 | -6.0 | 6.0 | 1.8e-09 | -0.99 | 0.02 | 0.98 | FALSE |
15 | The Cancer Genome Atlas | Brain Lower Grade Glioma | FBXW8 | 0.17 | 0.02 | blup | 83 | 0.03 | 7.0e-05 | 3.3 | 5.8 | 6.8e-09 | -0.70 | 0.04 | 0.72 | FALSE |
16 | The Cancer Genome Atlas | Lung Adenocarcinoma | FBXW8 | 0.10 | 0.08 | enet | 15 | 0.08 | 1.2e-09 | -5.6 | 6.0 | 1.8e-09 | -0.89 | 0.05 | 0.95 | TRUE |
17 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | FBXW8 | 0.11 | 0.12 | lasso | 6 | 0.12 | 3.1e-13 | -4.9 | 5.5 | 5.2e-08 | -0.91 | 0.07 | 0.93 | FALSE |
18 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | FBXW8 | 0.15 | 0.11 | blup | 79 | 0.13 | 7.7e-09 | -4.9 | 5.2 | 1.8e-07 | -0.89 | 0.16 | 0.84 | FALSE |
19 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | FBXW8 | 0.14 | 0.16 | lasso | 3 | 0.17 | 1.3e-07 | -5.0 | 5.3 | 9.5e-08 | -0.79 | 0.28 | 0.60 | FALSE |
20 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FBXW8 | 0.20 | 0.29 | lasso | 9 | 0.29 | 1.2e-30 | -5.6 | 5.4 | 5.8e-08 | -0.91 | 0.10 | 0.90 | FALSE |
21 | The Cancer Genome Atlas | Rectum Adenocarcinoma | FBXW8 | 0.13 | 0.17 | lasso | 7 | 0.10 | 2.0e-03 | -5.7 | 5.6 | 2.4e-08 | -0.91 | 0.03 | 0.68 | FALSE |
22 | The Cancer Genome Atlas | Soft Tissue Sarcoma | FBXW8 | 0.13 | 0.11 | enet | 18 | 0.12 | 7.0e-08 | -5.6 | 5.2 | 1.8e-07 | -0.78 | 0.06 | 0.94 | FALSE |
23 | The Cancer Genome Atlas | Stomach Adenocarcinoma | FBXW8 | 0.09 | 0.12 | lasso | 3 | 0.12 | 9.1e-09 | -5.0 | 5.3 | 1.1e-07 | -0.88 | 0.10 | 0.90 | FALSE |
24 | The Cancer Genome Atlas | Thyroid Carcinoma | FBXW8 | 0.22 | 0.16 | blup | 83 | 0.17 | 2.1e-16 | -5.6 | 5.6 | 2.6e-08 | -0.82 | 0.11 | 0.89 | FALSE |